Skip to content
  • Antibodies & Bispecifics
    • Antibody Platforms
    • Monoclonal Discovery
    • Bispecific Discovery
    • Optimization
  • TCR Mimics
  • Genetic Medicines
  • Cell Therapies
  • Partnering
    • Ecosystem Allies
  • About
    • Leadership
    • News and Events
    • Careers
    • Resources
  • Antibodies & Bispecifics
    • Antibody Platforms
    • Monoclonal Discovery
    • Bispecific Discovery
    • Optimization
  • TCR Mimics
  • Genetic Medicines
  • Cell Therapies
  • Partnering
    • Ecosystem Allies
  • About
    • Leadership
    • News and Events
    • Careers
    • Resources
Contact Us

Author: chrisbedi

米アロイ・セラピューティクス、 湘南ヘルスイノベーションパークに新拠点を設立

– 米バイオテクノロジー企業、アロイ・セラピューティクスが日本初の子会社を設立
– 主要モダリティである細胞治療の研究拠点を初めて日本に開設し、独自のiCAR-T技術を本格的に展開

Alloy Therapeutics Establishes Multi-Year Collaboration with Pfizer to Develop New Antibody Discovery Platform

Collaboration builds on Alloy’s existing and highly productive engagement with Pfizer and will apply Alloy’s innovation expertise to address Pfizer’s specific antibody discovery objectives

Contact Us

Democratizing access to foundational biologics discovery technologies & services.

Contact

@alloy-therapeutics-inc

info@alloytx.com

275 Second Ave, Suite 200, Waltham, MA 02451

Modalities

  • Antibodies & Bispecifics
  • TCR Mimics
  • Genetic Medicines
  • Cell Therapies

Ecosystem

  • Partnering
  • Ecosystem Allies

Company

  • About
  • Leadership
  • Careers

Insights

  • Resources
  • News & Events

© 2025 Alloy Therapeutics, Inc. All Rights Reserved. 

Privacy Policy | Terms & Conditions